measuregroup/AID162341

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103265230_AID162341_PMID15084117_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103183748_AID162341_PMID15084117_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103264882_AID162341_PMID15084117_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID163312453_AID162341_PMID15084117_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103181002_AID162341_PMID15084117_VALUE1
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35354
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Compound was evaluated for inhibition concentration of prostaglandin G/H synthase 2 in human blood
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103183748 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID163312453 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103265230 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103181002 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103264882
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID162341

Total number of triples: 15.